BackThermo Fisher Scientific Overview
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Target Price

Where could TMO trade next? Consensus target price: $630.

Get informed when a big investor buys or sells

+ Follow

Share Price

$654.8

Average Target Price

$628.004.1% downside

11 analysts in the last 4 months

High: $748 | Low: $510

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-25Deutsche Bank$72010% upsideOpen
2026-09-08UBS$73011.5% upsideOpen
2026-09-03CLSAMichael Luo$74814.2% upsideOpen
2026-08-05Stifel Nicolaus$6500.7% downsideOpen
2026-07-27Piper Sandler$6008.4% downsideOpen
2026-07-24Morgan Stanley$6500.7% downsideOpen
2026-07-24RBC CapitalDan Leonard$58011.4% downsideOpen
2026-07-23JefferiesTycho Peterson$6303.8% downsideOpen
2026-07-06Evercore ISI$57013% downsideOpen
2026-06-26Bernstein$52020.6% downsideOpen
2026-06-11Piper Sandler$51022.1% downsideOpen
2026-06-03HSBCSidharth Sahoo$54017.5% downsideOpen
2026-05-14RBC Capital$49025.2% downsideOpen
2026-04-27Morgan StanleyKallum Titchmarsh$6205.3% downsideOpen
2026-04-24Stifel NicolausDaniel Arias$6008.4% downsideOpen
2026-04-24Robert W. BairdCatherine Ramsey Schulte$6392.4% downsideOpen
2026-01-30Wells Fargo$6834.3% upsideOpen
2026-01-30Robert W. Baird$6530.3% downsideOpen
2026-01-30Barclays$6500.7% downsideOpen
2026-01-30UBS$6156.1% downsideOpen
2026-01-09Stifel NicolausDaniel Arias$7006.9% upsideOpen
2026-01-05Evercore ISIVijay Kumar$6500.7% downsideOpen
2025-12-15Wells Fargo$6753.1% upsideOpen
2025-12-09Goldman SachsEvie Koslosky$6854.6% upsideOpen
2025-12-07KeyBancPaul Knight$75014.5% upsideOpen
2025-10-29Argus Research$6106.8% downsideOpen
2025-10-28Morgan Stanley$6560.2% upsideOpen
2025-10-23UBS$5909.9% downsideOpen
2025-10-23Barclays$6254.6% downsideOpen
2025-10-22Leerink Partners$58011.4% downsideOpen
2025-10-08Redburn Partners$58011.4% downsideOpen
2025-10-08Redburn Partners$57512.2% downsideOpen
2025-10-02BarclaysLuke Sergott$58510.7% downsideOpen
2025-09-02RBC CapitalConor McNamara$56114.3% downsideOpen
2025-07-08UBSDan Leonard$46029.7% downsideOpen
2025-04-25Scotiabank$6057.6% downsideOpen
2025-04-23Goldman SachsMatthew Sykes$6106.8% downsideOpen
2025-01-31RBC CapitalConor McNamara$6935.8% upsideOpen
2025-01-02Evercore ISIVijay Kumar$58510.7% downsideOpen
2024-10-24Robert W. BairdCatherine Schulte$6225% downsideOpen
2024-10-23BarclaysLuke Sergott$6106.8% downsideOpen
2024-10-01Evercore ISIVijay Kumar$6303.8% downsideOpen
2024-09-20Stifel NicolausDaniel Arias$6803.8% upsideOpen
2024-09-20Robert W. BairdCatherine Schulte$6323.5% downsideOpen
2024-09-19CitigroupPatrick Donnelly$6205.3% downsideOpen
2024-09-18Deutsche BankJustin Bowers$6303.8% downsideOpen
2024-09-16Bank of America SecuritiesDerik de Bruin$6753.1% upsideOpen
2024-07-25Raymond JamesAndrew Cooper$6600.8% upsideOpen
2024-06-28BarclaysLuke Sergott$6008.4% downsideOpen
2024-04-30HSBCSidharth Sahoo$6702.3% upsideOpen

Thermo Fisher Scientific (TMO) FAQ

Thermo Fisher Scientific posts a target price of $630. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $630 for TMO means covering analysts, on average, see the stock 4.1% downside of $654.8 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TMO's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Thermo Fisher Scientific's other metric pages and overview cover the third.

Judging Thermo Fisher Scientific against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $630 here, then scan peer and history charts to see if the gap is persistent.